These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 37682463)
21. Efficacy and Safety of Preservative-free Latanoprost Eyedrops Compared with Preserved Prostaglandin Analogues in Patients with Open-angle Glaucoma. Seong HJ; Lee K; Lee SJ; Kim S; Park JW Korean J Ophthalmol; 2021 Jun; 35(3):235-241. PubMed ID: 34120423 [TBL] [Abstract][Full Text] [Related]
22. Ocular surface tolerability of prostaglandin analogs in patients with glaucoma or ocular hypertension. Whitson JT; Trattler WB; Matossian C; Williams J; Hollander DA J Ocul Pharmacol Ther; 2010 Jun; 26(3):287-92. PubMed ID: 20578283 [TBL] [Abstract][Full Text] [Related]
23. Corneal damage and its recovery after instillation of preservative-free versus preserved latanoprost eye drops. Inoue D; Mohamed YH; Uematsu M; Kitaoka T Cutan Ocul Toxicol; 2020 Jun; 39(2):158-164. PubMed ID: 32295438 [No Abstract] [Full Text] [Related]
24. Incidence of new coding for dry eye and ocular infection in open-angle glaucoma and ocular hypertension patients treated with prostaglandin analogs: retrospective analysis of three medical/pharmacy claims databases. Schwartz GF; Kotak S; Mardekian J; Fain JM BMC Ophthalmol; 2011 Jun; 11():14. PubMed ID: 21672240 [TBL] [Abstract][Full Text] [Related]
25. Corneal penetration into rabbit aqueous humor is comparable between preserved and preservative-free tafluprost. Pellinen P; Lokkila J Ophthalmic Res; 2009; 41(2):118-22. PubMed ID: 19147999 [TBL] [Abstract][Full Text] [Related]
26. Preservative-free versus preserved latanoprost eye drops in patients with open-angle glaucoma or ocular hypertension. Aptel F; Choudhry R; Stalmans I Curr Med Res Opin; 2016 Aug; 32(8):1457-63. PubMed ID: 27310103 [TBL] [Abstract][Full Text] [Related]
27. A Comparative Ocular Pharmacokinetics Study of Preservative-Free Latanoprost Unit-Dose Eye Drops and a Benzalkonium Chloride-Preserved Branded Product Following Topical Application to Rabbits. Zhou T; Miao Y; Li Z; Lu P; Liang Z; Yang J; He J; Xia H; Zhang Z; Zhang J J Ocul Pharmacol Ther; 2020 Sep; 36(7):522-528. PubMed ID: 32310714 [No Abstract] [Full Text] [Related]
29. In vivo corneal epithelial permeability following treatment with prostaglandin analogs [correction of analoges] with or without benzalkonium chloride. McCarey B; Edelhauser H J Ocul Pharmacol Ther; 2007 Oct; 23(5):445-51. PubMed ID: 17941807 [TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics and Pharmacology of Latanoprost 0.005% without Benzalkonium Chloride Vs Latanoprost 0.005% with Benzalkonium Chloride in New Zealand White Rabbits and Beagles. Halder A; Khopade AJ Curr Eye Res; 2021 Jul; 46(7):1031-1037. PubMed ID: 33719796 [No Abstract] [Full Text] [Related]
31. Polyquad-preserved travoprost/timolol, benzalkonium chloride (BAK)-preserved travoprost/timolol, and latanoprost/timolol in fixed combinations: a rabbit ocular surface study. Liang H; Brignole-Baudouin F; Pauly A; Riancho L; Baudouin C Adv Ther; 2011 Apr; 28(4):311-25. PubMed ID: 21424577 [TBL] [Abstract][Full Text] [Related]
32. Ocular surface status in glaucoma and ocular hypertension patients with existing corneal disorders switched from latanoprost 0.005% to tafluprost 0.0015%: comparison of two prostaglandin analogues with different concentrations of benzalkonium chloride. Wong TT; Aung T; Ho CL Clin Exp Ophthalmol; 2018 Dec; 46(9):1028-1034. PubMed ID: 29802759 [TBL] [Abstract][Full Text] [Related]
33. Latanoprost-loaded cyclodextrin microaggregate suspension eye drops for enhanced bioavailability and stability. Zhou X; Li X; Xu J; Cheng Y; Cao F Eur J Pharm Sci; 2021 May; 160():105758. PubMed ID: 33588044 [TBL] [Abstract][Full Text] [Related]
34. Effects of SofZia-preserved travoprost and benzalkonium chloride-preserved latanoprost on the ocular surface -- a multicentre randomized single-masked study. Aihara M; Oshima H; Araie M; Acta Ophthalmol; 2013 Feb; 91(1):e7-e14. PubMed ID: 23241328 [TBL] [Abstract][Full Text] [Related]
35. Long-term effect of BAK-free travoprost on ocular surface and intraocular pressure in glaucoma patients after transition from latanoprost. Aihara M; Otani S; Kozaki J; Unoki K; Takeuchi M; Minami K; Miyata K J Glaucoma; 2012 Jan; 21(1):60-4. PubMed ID: 21278589 [TBL] [Abstract][Full Text] [Related]
36. Effect of preservative-free and preserved prostaglandin analogues on the histology of cornea of adult male guinea pigs following repeated exposure. Ali AF; Salama RM; Soliman MA Folia Morphol (Warsz); 2022; 81(1):52-64. PubMed ID: 33438192 [TBL] [Abstract][Full Text] [Related]
37. Ocular surface tolerability of prostaglandin analogs and prostamides in patients with glaucoma or ocular hypertension. Crichton AC; Vold S; Williams JM; Hollander DA Adv Ther; 2013 Mar; 30(3):260-70. PubMed ID: 23475405 [TBL] [Abstract][Full Text] [Related]
38. Excipients of preservative-free latanoprost induced inflammatory response and cytotoxicity in immortalized human HCE-2 corneal epithelial cells. Smedowski A; Paterno JJ; Toropainen E; Sinha D; Wylegala E; Kaarniranta K J Biochem Pharmacol Res; 2014 Dec; 2(4):175-184. PubMed ID: 25530926 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of the cytotoxic effects of ophthalmic solutions containing benzalkonium chloride on corneal epithelium using an organotypic 3-D model. Khoh-Reiter S; Jessen BA BMC Ophthalmol; 2009 Jul; 9():5. PubMed ID: 19638217 [TBL] [Abstract][Full Text] [Related]
40. Relative efficacy and safety of preservative-free latanoprost (T2345) for the treatment of open-angle glaucoma and ocular hypertension: an adjusted Indirect comparison meta-analysis of randomized clinical trials. Cucherat M; Stalmans I; Rouland JF J Glaucoma; 2014 Jan; 23(1):e69-75. PubMed ID: 23881267 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]